CB vs HDB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CB exhibits a stable financial profile with a Piotroski F-Score of 4/9 and a current price ($329.99) aligned almost perfectly with its Graham Number ($330.04), providing a strong defensive floor. The company demonstrates exceptional earnings power with 27.9% YoY growth and a consistent track record of beating estimates over 25 quarters. While insider sentiment is bearish and technical trends are currently weak, the low P/E ratio relative to the sector and strong ROE suggest significant fundamental value. The substantial gap between the defensive fair value and the growth-based intrinsic value ($757.27) indicates long-term upside potential.
HDB exhibits a stable financial health profile with a Piotroski F-Score of 5/9, though it lacks an Altman Z-Score as is typical for banking institutions. The current price of $25.71 is almost perfectly aligned with its growth-based intrinsic value of $26.1, suggesting the stock has reached a fundamental floor after a severe correction. While the company maintains a strong track record of earnings surprises and a 'Strong Buy' analyst consensus, these are offset by negative YoY revenue growth and a completely bearish technical trend (0/100). The valuation is further complicated by an exceptionally high Price-to-Book ratio of 10.61, which is aggressive for the regional banking sector.
Compare Another Pair
Related Comparisons
CB vs HDB: Head-to-Head Comparison
This page compares Chubb Limited (CB) and HDFC Bank Limited (HDB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.